Table 2.
Hepatitis B virus (HBV) antiviral agents against COVID-19
Entry | Name | Biological activity against COVID-19 | Mechanism |
---|---|---|---|
1 | Famciclovir | ND | Inhibits viral DNA polymerase |
2 | Entecavir | EC50: > 10 µM, CC50: > 50 µM [23] | Inhibits reverse transcription |
3 | Telbivudine | ND | Reverse transcriptase inhibitor |
4 | Foscarnet | ND | Viral DNA polymerases inhibitor |